Botox 100 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FBYLN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,360
Award facts
- Contract value 100% obligated
- $2,360.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,360.45 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of BOTOX 100 unit vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 18, 2025, and was awarded on November 26, 2025. No set-aside designation was used in this competitive award. This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion federal acquisition strategy designed to supply pharmaceutical products to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has demonstrated substantial federal contracting capability as an established supplier within the Defense Logistics Agency's Medical Supply Chain division, with prior delivery orders spanning a diverse portfolio of branded and generic pharmaceuticals, biologics, vaccines, and medical consumables. The company holds a single-award IDC under PPV-G GEN V with a ceiling value of $499,999,999 and a completion date of December 31, 2036, positioning it as a critical regional pharmaceutical supplier for military healthcare operations. The BOTOX delivery order represents a routine fulfillment of specialized pharmaceutical requirements under this broader prime vendor framework, supporting the Department of Defense's medical supply needs across its global healthcare network.
Quick answers
Who was awarded contract SPE2DR26FBYLN?
SPE2DR26FBYLN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26FBYLN worth?
The government has obligated $2,360 on SPE2DR26FBYLN.
Is contract SPE2DR26FBYLN an order under another contract?
Yes. SPE2DR26FBYLN is a delivery order under SPE2DR25D9103, an indefinite delivery contract.
Was contract SPE2DR26FBYLN competed?
The extent of competition for SPE2DR26FBYLN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award